Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Anindita Mukerjee"'
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3990-3995 (2015)
Treatments utilizing monoclonal antibody therapeutics against intracellular protein-protein interactions in cancer cells have been hampered by several factors, including poor intracellular uptake and rapid lysosomal degradation. Our current work exam
Externí odkaz:
https://doaj.org/article/66a394bed0324485b4ea7d8a5a170212
Autor:
Francesca Marzoli, Amalendu Prakash Ranjan, Amalia Di Giannuario, Rita Di Giovannandrea, Anindita Mukerjee, Stefano Pieretti, Jamboor K. Vishwanatha
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 158:379-386
Given the poor bioavailability of curcumin, its antinociceptive effects are produced after chronic intravenous administration of high doses, while poly (d,l-lactide-co-glycolide)-loaded vesicles (PLGA) can improve drug delivery. This paper investigat
Autor:
Andrew Gdowski, Jamboor K. Vishwanatha, Anindita Mukerjee, Jana B. Lampe, Rohan P. Joshi, Victor Lin, Yu-Chieh Wang, Amalendu Prakash Ranjan
Publikováno v:
ACS Appl Nano Mater
Targeting therapeutic agents to specific organs in the body remains a challenge despite advances in the science of systemic drug delivery. We have engineered a programmable-bioinspired nanoparticle (P-BiNP) delivery system to simultaneously target th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d0cc376358f18c3d0499b18cf7507f
https://europepmc.org/articles/PMC7880042/
https://europepmc.org/articles/PMC7880042/
Autor:
Annie Bouchard, Amalendu Prakash Ranjan, Muhammed Majeed, Jamboor K. Vishwanatha, Andrew Gdowski, Anindita Mukerjee, Lawrence Helson
Publikováno v:
Journal of Biomedical Nanotechnology. 12:679-688
Non-small-cell lung cancer therapy is a challenge due to poor prognosis and low survival rate. There is an acute need for advanced therapies having higher drug efficacy, low immunogenicity and fewer side effects which will markedly improve patient co
Publikováno v:
Journal of biomedical nanotechnology. 12(7)
A major challenge in pharmaceutical research is effective targeting strategies to their sites of action. Emerging knowledge and the current progress in nanotechnology based delivery systems has opened up exciting ways towards successful targeted nano
Autor:
Victor Lin, Jamboor K. Vishwanatha, Jana B. Lampe, Amalendu Prakash Ranjan, Yu-Chieh Wang, Andrew Gdowski, Anindita Mukerjee
Publikováno v:
Journal of Clinical Oncology. 37:e14637-e14637
e14637 Background: We have engineered a programmable-bioinspired nanoparticle (P-BiNP) delivery system to simultaneously target the bone and increase uptake in homotypic tumor cells by coating polymeric nanoparticles with programmed cancer cell membr
Autor:
Karen S. Anderson, William L. Jorgensen, Amalendu Prakash Ranjan, Daniel J. Czyzyk, A. Clinton White, Pinar Iyidogan, Jamboor K. Vishwanatha, José A. Cisneros, Alejandro Castellanos-Gonzalez, Anindita Mukerjee
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:2065-2067
Cryptosporidiosis, a gastrointestinal disease caused by protozoans of the genus Cryptosporidium, is a common cause of diarrheal diseases and often fatal in immunocompromised individuals. Cryptosporidium hominis (C. hominis)-specific bifunctional thym
Autor:
Marjana R Sarker, Anindita Mukerjee, Amalendu Prakash Ranjan, Jamboor K. Vishwanatha, Joe Kimbell, Andrew Gdowski
Publikováno v:
Journal of Urology. 195
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3990-3995 (2015)
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3990-3995 (2015)
Treatments utilizing monoclonal antibody therapeutics against intracellular protein-protein interactions in cancer cells have been hampered by several factors, including poor intracellular uptake and rapid lysosomal degradation. Our current work exam